These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11441312)

  • 61. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection.
    Lencioni R; Caramella D; Bartolozzi C
    Radiology; 1995 Jan; 194(1):113-8. PubMed ID: 7997536
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Percutaneous ethanol injection therapy of hepatoma].
    Shiina S; Imamura M
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2008-11. PubMed ID: 8586922
    [No Abstract]   [Full Text] [Related]  

  • 63. Ultrasound guided percutaneous ethanol treatment of hepatic neoplasms: a therapeutic alternative in the nineties.
    Bastid C; Azar C; Sahel J
    Ultrasound Med Biol; 1995; 21(1):129-31. PubMed ID: 7754573
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Subcutaneous metastasis following percutaneous ethanol injection therapy for hepatocellular carcinoma.
    Yano S; Nakamura K; Yamane K; Kakinuma T; Asahina A; Tamaki K
    Acta Derm Venereol; 2001; 81(3):213-4. PubMed ID: 11558885
    [No Abstract]   [Full Text] [Related]  

  • 66. Current role of local ablative treatments for hepatocellular carcinoma.
    Huang GT; Liang JD; Sheu JC
    J Formos Med Assoc; 2004 Jun; 103(6):403-10. PubMed ID: 15278182
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?
    Cabibbo G; Antonucci M; Sacco R; Sciarrino E
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):147-50. PubMed ID: 25558787
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Review article: percutaneous treatment of hepatocellular carcinoma.
    Gaiani S; Celli N; Cecilioni L; Piscaglia F; Bolondi L
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():103-10. PubMed ID: 12786621
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy.
    Lee MJ; Mueller PR; Dawson SL; Gazelle SG; Hahn PF; Goldberg MA; Boland GW
    AJR Am J Roentgenol; 1995 Jan; 164(1):215-20. PubMed ID: 7998542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Percutaneous ethanol injection in bleeding hepatocellular carcinoma.
    Joly JP; Yzet T; Dupas JL; Capron JP
    AJR Am J Roentgenol; 1992 Dec; 159(6):1344-5. PubMed ID: 1332457
    [No Abstract]   [Full Text] [Related]  

  • 72. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
    Koda M; Murawaki Y; Mitsuda A; Ohyama K; Horie Y; Suou T; Kawasaki H; Ikawa S
    Cancer; 2000 Feb; 88(3):529-37. PubMed ID: 10649243
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Percutaneous microwave coagulation therapy for hepatocellular carcinoma located on the surface of the liver.
    Ohmoto K; Tsuduki M; Shibata N; Takesue M; Kunieda T; Yamamoto S
    AJR Am J Roentgenol; 1999 Nov; 173(5):1231-3. PubMed ID: 10541094
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
    Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
    Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fatal liver necrosis following percutaneous ethanol injection for hepatocellular carcinoma.
    Taavitsainen M; Vehmas T; Kauppila R
    Abdom Imaging; 1993; 18(4):357-9. PubMed ID: 8220036
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US.
    Bartolozzi C; Lencioni R; Ricci P; Paolicchi A; Rossi P; Passariello R
    Radiology; 1998 Nov; 209(2):387-93. PubMed ID: 9807563
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma (HCC).
    Mueller PR
    Jpn J Cancer Res; 1995 Nov; 86(11):inside front cover. PubMed ID: 8567388
    [No Abstract]   [Full Text] [Related]  

  • 78. Echo-guided percutaneous ethanol injection in small hepatocellular carcinoma: personal experience.
    Solmi L; Muratori R; Bertoni F; Gandolfi L
    Hepatogastroenterology; 1993 Oct; 40(5):505-8. PubMed ID: 8270245
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Chemoembolization and ethanol ablation of primary hepatic carcinoma and metastatic tumors].
    Rudzki S; Jamroz A
    Pol Merkur Lekarski; 2004 Jan; 16(91):78-81. PubMed ID: 15074029
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Standard therapy for primary hepatocellular carcinoma].
    Ye SL
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):449-50. PubMed ID: 15329199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.